Karno M, Golding JM, Sorenson SB, Burnam MA . The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry 1988; 45: 1094–1099.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association: Washington, DC, 1994, p 886.
World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. World Health Organization: Geneva, 1992.
Leckman JF, Grice DE, Boardman J, Zhang H, Vitale A, Bondi C et al. Symptoms of obsessive-compulsive disorder. Am J Psychiatry 1997; 154: 911–917.
Gottesman II, Gould TD . The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003; 160: 636–645.
Pauls DL, Alsobrook JP, Goodman W, Rassmussen S, Leckman JF . A family study of obsessive-compulsive disorder. Am J Psychiatry 1995; 152: 76–84.
Nestadt G, Samuels J, Riddle M, Bienvenu JO, Liang KY, LaBuda M et al. A family study of obsessive-compulsive disorder. Arch Gen Psychiatry 2000; 57: 358–363.
Rasmussen SA, Tsuang MT . The epidemiology of obsessive compulsive disorder. Clin Psychiatry 1984; 45: 450–457, (review).
Grados M, Riddle MA, Samuels JF, Liang KY, Hoehn-Saric R, Bienvenu OJ et al. The familial phenotype of obsessive-compulsive disorder in relation to tic disorders. Biol Psychiatry 2001; 50: 559–565.
Bienvenu OJ, Samuels J, Riddle MA, Hoehn-Saric R, Liang KY, Cullen BAM et al. The relationship of obsessive-compulsive disorder to possible spectrum disorders: results from a family study. Biol Psychiatry 2000; 48: 287–293.
Samuels J, Nestadt G, Bienvenu OJ, Costa Jr PT, Riddle MA, Liang KY et al. Personality disorders and normal personality dimensions in obsessive-compulsive disorder. Br J Psychiatry 2000; 177: 457–462.
Nicolini H, Hanna G, Baxter L, Schwartz J, Weissbacker K, Spence MA . Segregation analysis of obsessive-compulsive and associated disorders. Preliminary results. Ursus Medicus 1991; 1: 25–28.
Cavallini MC, Perna G, Caldirola D, Bellodi L . A segregation study of panic disorder in families of panic patients responsive to the 35% CO2 challenge. Biol Psychiatry 1999; 46: 815–820.
Alsobrook JP, Leckman JF, Goodman WK, Rasmussen SA, Pauls DL . Segregation analysis of obsessive-compulsive disorder using symptom-based factor scores. Am J Med Genet 1999; 88: 669–675.
Pato MT, Pato CN, Pauls DL . Recent findings in the genetics of OCD. J Clin Psychiatry 2002; 63(Suppl 6): 30–33.
McDougle CJ, Goodman WK, Leckman JF, Lee NC, Heninger GR, Price LH . Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics. Arch Gen Psychiatry 1994; 51: 302–308.
Nordstron EJ, Burton FH . A transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder circuitry. Mol Psychiatry 2002; 7: 617–625, 524.
Rosenberg D, Hanna G . Genetic and imaging strategies in obsessive-compulsive disorder: potential implications for treatment development. Biol Psychiatry 2000; 48: 1210–1222.
Geller D, Biederman J, Jones J, Park K, Schwartz S, Shapiro S et al. Is juvenile obsessive-compulsive disorder a developmental subtype of the disorder? A review of the pediatric literature. J Am Acad Child Adolesc Psychiatry 1998; 37: 420–427.
Eichstedt JA, Arnold SL . Childhood-onset obsessive-compulsive disorder: a tic-related subtype of OCD? Clin Psychol Rev 2001; 21: 137–158.
Rosario-Campos MC, Leckman F, Mercadante MT, Shavitt G, Prado HS, Sada P et al. Adults with early-onset obsessive-compulsive disorder. Am J Psychiatry 2001; 158: 1899–1903.
Diniz J, Rosario-Campos MC, Shavitt RG, Curi M, Hounie AG, Brotto SA et al. Impact of age of onset and duration of illness in the expression of comorbidities in obsessive-compulsive disorder. J Clin Psychiatry 2004; 65: 22–27.
Swedo SE, Rapoport JL . Phenomenology and differential diagnosis of obsessive-compulsive disorder in children and adolescents. In: Rapoport JL (ed) Obsessive-compulsive Disorder in Children and Adolescents. American Psychiatric Press: Washington, DC, 1989, pp 13–32.
Zohar AH, Pauls DL, Ratzone G, Apter A, Dycian A, Binder M et al. Obsessive-compulsive disorder with and without tics in an epidemiological sample of adolescents. Am J Psychiatry 1997; 154: 274–276.
Geller DA, Biederman J, Faraone SV, Cradock K, Hagermoser L, Zaman N et al. Attention-deficit/hyperactivity disorder in children and adolescents with obsessive-compulsive disorder: fact or artifact? J Am Acad Child Adolesc Psychiatry 2002; 41: 52–58.
Geller DA, Biederman J, Griffin S, Jones J, Lefkowitz TR . Comorbidity of juvenile obsessive-compulsive disorder with disruptive behavior disorders. J Am Acad Child Adolesc Psychiatry 1996; 35: 1637–1646.
Piacentini J . Cognitive behavioral therapy of childhood OCD. Child Adolesc Psychiatric Clin N Am 1999; 8: 599–616.
Leonard HL, Lenane MC, Swedo SE, Rettew DC, Gershon ES, Rapopport JL . Tics and Tourette's disorder: a 2- to 7- year follow-up of 54 obsessive-compulsive children. Am J Psychiatry 1992; 149: 1244–1251.
Reddy PS, Reddy YC, Srinath S, Khanna S, Sheshadri SP, Girimaji SR . A family study of juvenile obsessive-compulsive disorder. Can J Psychiatry 2001; 46: 346–351.
Lenane MC, Swedo SE, Leonard H, Pauls DL, Sceery W, Rapoport J . Psychiatric disorders in first degree relatives of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 1990; 29: 407–412.
Riddle MA, Scahill L, King R, Hardin MT, Towbin KE, Ort SI et al. Obsessive-compulsive disorder in children and adolescents: phenomenology and family history. J Am Acad Child Adolesc Psychiatry 1990; 29: 766–772.
Rosario-Campos MC, Leckman JF, Curi M, Quatrano S, Katsovitch L, Miguel EC et al A family study of early-onset obsessive-compulsive disorder. Am J Med Genet, in press.
March JS, Leonard HL . Obsessive-compulsive disorder in children and adolescents: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 1996; 35: 1265–1273.
Busatto GF, Zamignani DR, Buchpiguel CA, Garrido GEJ, Glabus MF, Rocha ET et al. A voxel based investigation of regional cerebral blood flow abnormalities in obsessive-compulsive disorder using single photon emission computed tomography (SPECT). Psychiatry Res 2000; 99: 15–27.
Ackerman DL, Greenland S, Bystritsky A, Morgenstern H, Katz RJ . Predictors of treatment response in obsessive-compulsive disorder: multivariate analyses from a multicenter trial of clomipramine. J Clin Psychopharmacol 1994; 14: 247–254.
Ravizza L, Barzega G, Bellino S, Bogetto F, Maina G . Predictors of drug treatment response in obsessive-compulsive disorder. J Clin Psychiatry 1995; 56: 368–373.
Shavitt RG, Belotto C, Curi M, Hounie AG, Rosário-Campos MC, Diniz JB et al. Sensory phenomena and treatment response in obsessive-compulsive disorder, submitted.
Miguel EC, Shavitt RG, Ferrão YA, Brotto SA, Diniz JB . How to treat OCD in patients with Tourette's syndrome. J Psychosom Res 2003; 55: 49–57.
Walitza S, Wewetzer C, Warnke A, Gerlach M, Geller F, Gerber G et al. 5-HT2A promoter polymorphism −1438G/A in children and adolescents with obsessive-compulsive disorders. Mol Psychiatry 2002; 7: 1054–1057.
Hanna GL, Piacentini J, Cantwell DP, Fischer DJ, Himle JA, Van Etten M . Obsessive-compulsive disorder with and without tics in a clinical sample of children and adolescents. Depress Anxiety 2002; 16: 59–63.
Veenstra-VanderWeele J, Kim SJ, Gonen D, Hanna GL, Leventhal BL, Cook EH . Genomic organization of the SLC1A1/EAAC1 gene and mutation screening in early-onset obsessive-compulsive disorder. Mol Psychiatry 2001; 6: 160–167.
Fontanelle L, Marques C, Versiani M . The effect of gender on the clinical features and therapeutic response in obsessive-compulsive disorder. Rev Bras Psiquiatria 2002; 24: 7–11.
Miguel EC, Coffey BJ, Baer L, Savage CR, Rauch SL, Jenike MA . Phenomenology of intentional repetitive behaviors in obsessive-compulsive disorder and Tourette's syndrome. J Clin Psychiatry 1995; 56: 246–255.
Miguel EC, Rauch SL, Jenike MA . Obsessive-compulsive disorder. Psychiatric Clin N Am 1997; 20: 863–883.
Pauls DL, Towbin KE, Leckman JF, Zahner GE, Cohen DJ . Gilles de la Tourette's syndrome and obsessive-compulsive disorder: evidence supporting a genetic relationship. Arch Gen Psychiatry 1986; 43: 1180–1182.
Pauls DL, Raymond CL, Stevenson JM, Leckman JF . A family study of Gilles de la Tourette syndrome. Am J Hum Genet 1991; 48: 154–163.
Comings DE, Comings BG . A controlled study of Tourette syndrome. IV. Obsessions, compulsions, and schizoid behaviors. Am J Hum Genet 1987; 41: 782–803.
Robertson MM, Trimble MR, Lees AJ . The psychopathology of the Gilles de la Tourette syndrome. A phenomenological analysis. Br J Psychiatry 1988; 152: 383–390.
Pauls DL, Leckman JF . The inheritance of Gilles de la Tourette's syndrome and associated behaviors: evidence for autosomal dominant transmission. N Engl J Med 1986; 315: 993–997.
Eapen V, Pauls DL, Robertson MM . Evidence for autosomal dominant transmission in Tourette's syndrome—United Kingdom Cohort Study. Br J Psychiatry 1993; 162: 593–596.
Van de Wetering BJM . The Gilles de la Tourette syndrome. A psychiatric–genetic study. PhD theses, Erasmus University, Rotterdam.
Miguel EC, do Rosario-Campos MC, Shavitt RG, Hounie AG, Mercadante MT . The tic-related obsessive-compulsive disorder phenotype and treatment implications. Adv Neurol 2001; 85: 43–55, (review).
Miguel EC, Rosario-Campos MC, Shavitt RG, Hounie AG, Mercadante MT . The tic-related obsessive-compulsive disorder phenotype. Adv Neurol 2000; 85: 43–55.
Swerdlow NR, Zinner S, Farber RH, Seacrist C, Hartston H . Symptoms in obsessive-compulsive disorder and Tourette syndrome: a spectrum? CNS Spectrums 1999; 4: 21–33.
Petter T, Richter MA, Sandor P . Clinical features distinguishing patients with Tourette's syndrome and obsessive-compulsive disorder from patients with obsessive-compulsive disorder without tics. J Clin Psychiatry 1998; 59: 456–459.
Eapen V, Robertson MM, Alsobrook II JP, Pauls DL . Obsessive-compulsive symptoms in Gilles de la Tourette's syndrome and obsessive-compulsive disorder: differences by diagnosis and family history. Am J Med Genet 1997; 74: 432–438.
Holzer JC, Goodman WK, McDougle CJ, Baer L, Boyarsky BK, Leckman JF et al. Obsessive-compulsive disorder with and without a chronic tic disorder: a comparison of symptoms in 70 patients. Br J Psychiatry 1994; 164: 469–473.
George MS, Trimble MR, Ring HA, Sallee FR, Robertson MM . Obsessions in obsessive-compulsive disorder with and without Gilles de la Tourette's syndrome. Am J Psychiatry 1993; 105: 93–97.
Pitman RK . Pierre Janet on obsessive-compulsive disorder (1903). Arch Gen Psychiatry 1987; 44: 226–232.
Rasmussen AS, Tsuang MT . Clinical characteristics and family history in DSM-III obsessive compulsive disorder. Am J Psychiatry 1986; 143: 317–322.
Leckman JF, Walker DE, Goodman WK, Pauls DL, Cohen DJ . ‘Just-right’ perceptions associated with compulsive behavior in Tourette's syndrome. Am J Psychiatry 1994; 151: 675–680.
Leckman JF, Goodman WK, Anderson GM, Riddle MA, Chappell PB, McSwiggan-Hardin Mt et al. Cerebrospinal fluid biogenic amines in obsessive compulsive disorder, Tourette's syndrome, and healthy controls. Neuropsychopharmacology 1995; 12: 73–86.
Mataix-Cols D, Rauch SL, Manzo PA, Jenike MA, Baer L . Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Am J Psychiatry 1999; 156: 1409–1416.
Baer L . Factor analysis of symptom subtypes of obsessive compulsive disorder and their relation to personality and tic disorders. J Clin Psychiatry 1994; 55: 18–23.
Coffey BJ, Miguel EC, Biederman J, Baer L, Rauch SL, O'Sullivan RL et al. Tourette's disorder with and without obsessive-compulsive disorder in adults: are they different? J Nerv Ment Dis 1998; 186: 201–206.
Bliss J . Sensory experiences of Gilles de la Tourette syndrome. Arch Gen Psychiatry 1980; 37: 1343–1347.
Shapiro AK, Shapiro ES, Young JG, Feinberg TE . Gilles de la Tourette Syndrome. Raven Press: New York, 1988.
Kurlan R, Lichter D, Hewitt D . Sensory tics in Tourette's syndrome. Neurology 1989; 39: 731–734.
Cohen AJ, Leckman JF . Sensory phenomena associated with Gilles de la Tourette's syndrome. J Clin Psychiatry 1992; 53: 319–323.
Leckman JF, Walker DE, Cohen DJ . Premonitory urges in Tourette's syndrome. Am J Psychiatry 1993; 150: 98–102.
Chee KY, Sachdev P . A controlled study of sensory tics in Gilles de la Tourette syndrome and obsessive-compulsive disorder using a structured interview. J Neurol Neurosurg Psychiatry 1997; 62: 188–192.
Rosário-Campos MC . Transtorno obsessivo-compulsivo de início precoce e de início tardio: características clínicas, psicopatológicas e de comorbidade. Dissertação de mestrado, Faculdade de Medicina da Universidade de São Paulo, São Paulo 1998, p 99.
Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischman RL, Hill CL et al. The Yale–Brown obsessive-compulsive scale: I. development use and reliability. Arch Gen Psychiatry 1989; 46: 1006–1011.
Hantouche EG, Lancrenon S . Modern typology of symptoms and obsessive-compulsive syndromes: results of a large French study of 615 patients. Encephale 1996; 22: 9–21.
Summerfeldt LJ, Richter MA, Anthony MM, Huta VM, Swinson RP . Symptom structure in obsessive-compulsive disorder: factor analytic evidence for subgroups. Poster presented at the 150th Annual Meeting of the American Psychiatric Association, San Diego, CA, May 1997.
Summerfeldt LJ, Richter MA, Antony MM, Swinson RP . Symptom structure in obsessive-compulsive disorder: a confirmatory factor-analytic study. Behav Res Ther 1999; 37: 297–311.
Mataix-Cols D, Rauch SL, Baer L, Eisen JL, Shera DM, Goodman WK et al. Symptom stability in adult obsessive compulsive disorder: data from a naturalistic two-year follow-up study. Am J Psychiatry 2002; 159: 263–268.
Tek C, Ulug B . Religiosity and religious obsessions in obsessive-compulsive disorder. Psychiatry Res 2001; 104: 99–108.
Cavallini MC, Di Bella D, Siliprandi F, Malchiodi F, Bellodi L . Exploratory factor analysis of obsessive-compulsive patients and association with 5-HTTLPR polymorphism. Am J Med Genet 2002; 114: 347–353.
Foa EB, Huppert JD, Leiberg S, Langner R, Kichic R, Hajcak G et al. The obsessive-compulsive inventory: development and validation of a short version. Psychol Assess 2002; 14: 485–496.
Feinstein SB, Fallon BA, Petkova E, Liebowitz MR . Item-by-item factor analysis of the Yale–Brown Obsessive Compulsive Scale Symptom Checklist. J Neuropsychiatry Clin Neurosci 2003; 15: 187–193.
Leckman JF, Pauls DL, Zhang H, Rosario-Campos MC, Katsovich L, Kidd KK et al. Tourette Syndrome Association International Consortium for Genetics. Obsessive-compulsive symptom dimensions in affected sibling pairs diagnosed with Gilles de la Tourette syndrome. Am J Med Genet 2003; 116B: 60–68.
Mataix-Cols D, Rosario-Campos MC, Leckman JF . A multidimensional model of obsessive-compulsive disorder. Am J Psychiatry, in press.
Mataix-Cols D, Cullen S, Lange K, Zelaya F, Andrew C, Amaro E et al. Neural correlates of anxiety associated with obsessive-compulsive symptom dimensions in normal volunteers. Biol Psychiatry 2003; 53: 482–493.
Mataix-Cols D, Fullana MA, Alonso P, Menchon JM, Vallejo J . Convergent and discriminate validity of the Yale–Brown Obsessive-Compulsive Scale Symptom Checklist. Psychother Psychosom, in press.
Zhang H, Leckman JF, Tsai C-P, Kidd KK, Rosario Campos MC . The Tourette Syndrome Association International Consortium for Genetics: genome wide scan of hoarding in sibling pairs both diagnosed with Gilles de la Tourette syndrome. Am J Hum Genet 2002; 70: 896–904.
Black DW, Monahan P, Gable J, Blum N, Clancy G, Baker P . Hoarding and treatment response in 38 nondepressed subjects with obsessive-compulsive disorder. J Clin Psychiatry 1998; 59: 420–425.
Alonso P, Menchon JM, Pifarre J, Mataix-Cols D, Torres L, Salgado P et al. Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy. J Clin Psychiatry 2001; 62: 535–540.
Saxena S, Maidment KM, Vapnik T, Golden G, Rishwain T, Rosen RM et al. Obsessive-compulsive hoarding: symptom severity and response to multimodal treatment. J Clin Psychiatry 2002; 63: 21–27.
Rauch SL, Dougherty DD, Shin LM, Alpert NM, Manzo P, Leahy L et al. Neural correlates of factor-analyzed OCD symptom dimensions: a PET study. CNS Spectrums 1998; 3: 37–43.
The Tourette Syndrome International Consortium for Genetics. A complete genome screen in sib pairs affected by Gilles de la Tourette syndrome. Am J Hum Genet 1999; 65: 1428–1436.
McHugh PR, Slavney PR (eds). The Perspectives of Psychiatry. Johns Hopkins: Baltimore, 1988.
Costa Jr PT, McCrae RR . Revised NEO Personality Inventory (NEO PI-R) Professional Manual. Psychological Assessment Resources: Odessa, FL, 1992.
Lesch K-P, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274: 1527–1531.
Greenberg BD, Li Q, Lucas FR, Hu S, Sirota LA, Benjamin J et al. Association between the serotonin transporter promoter polymorphism and personality traits in a primarily female population sample. Am J Med Genet 2000; 96: 202–216.
Jacob CP, Strobel A, Hohenberger K, Ringel T, Gutknecht L, Reif A et al. Association between allelic variation of serotonin transporter function and neuroticism in anxious cluster C personality disorders. Am J Psychiatry 2004; 161: 569–572.
Nestadt G, Samuels J, Riddle MA, Liang K-Y, Bienvenu OJ, Hoehn-Saric R et al. The relationship between obsessive-compulsive disorder and anxiety and affective disorders: results from the Johns Hopkins OCD family study. Psychol Med 2001; 31: 481–487.
Bienvenu OJ, Samuels JF, Riddle MA, Hoehn-Saric R, Liang KY, Cullen BAM et al. The relationship of obsessive-compulsive disorder to possible spectrum disorders: results from a family study. Biol Psychiatry 2000; 48: 287–293.
Gonzales CH . Estudo de famílias no transtorno obsessivo-compulsivo. Tese de doutorado—Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, 2003, p 227.
Cavallaro R, Galardi G, Cavallini MC, Henin M, Amodio S, Bellodi L et al. Obsessive compulsive disorder among idiopathic focal dystonia patients: an epidemiological and family study. Biol Psychiatry 2002; 52: 356–361.
Nestadt G, Addington A, Samuels J, Liang K, Bienvenu OJ, Riddle M et al. The identification of OCD-related subgroups based on comorbidity. Biol Psychiatry 2003; 53: 914–920.
Chacon P, Rosario-Campos MC, Hounie AG, Lopes AC, Curi M, Miguel EC . Comment on ‘the identification of OCD-related subgroups based on comorbidity’. Biol Psychiatry 2004; 55: 960–961.
Faraone SV, Tsuang MT, Tsuang DW (eds). Genetics of Mental Disorders: A Guide for Students, Clinicians, and Researchers. The Guilford Press: New York, 1999, p 272.
Torres AR, Dedomenico AM, Crepaldi AL, Miguel EC . Obsessive-compulsive symptoms in patients with panic disorder. Compr Psychiatry 2004; 45: 219–224.
Bellodi L, Cavallini MC, Bertelli S, Chiapparino D, Riboldi C, Smeraldi E . Morbidity risk for obsessive-compulsive spectrum disorders in first-degree relatives of patients with eating disorders. Am J Psychiatry 2001; 158: 563–569.
Dykens E, Shah B . Psychiatric disorders in Prader–Willi syndrome: epidemiology and management. CNS Drugs 2003; 17: 167–178.
Clarke DJ, Boer H, Whittington A, Holland JB . Prader–Willi syndrome, compulsive and ritualistic behaviors: the first population-based survey. Br J Psychiatry 2002; 180: 358–362.
Wigren M, Hansen S . Rituals and compulsivity in Prader–Willi syndrome: profile and stability. J Intellect Disabil Res 2003; 47: 428–438.
Dykens EM, Leckman JF, Cassidy SB . Obsessions and compulsions in Prader–Willi syndrome. J Child Psychol Psychiatry 1996; 37: 995–1002.
State MW, Dykens EM, Rosner B, Martin A, King BH . Obsessive-compulsive symptoms in Prader–Willi and ‘Prader–Willi-like’ patients. J Am Acad Child Adolesc Psychiatry 1999; 38: 329–334.
Wassink TH, Piven J, Patil SR . Chromosomal abnormalities in a clinic sample of individuals with autistic disorder. Psychiatr Genet 2001; 11: 57–63.
Hollander E, King A, Delaney K, Smith CJ, Silverman JM . Obessive-compulsive behaviors in parents of multiplex autism families. Psychiatry Res 2003; 117: 11–16.
Millet B, Chabane N, Delorme R, Leboyer M, Leroy S, Poirier MF et al. Association between the dopamine receptor D4 (DRD4) gene and obsessive-compulsive disorder. Am J Med Genet 2003; 116B: 55–59.
Cruz C, Camarena B, King N, Páez F, Sidenberg D, Fuente JR et al. Increased prevalence of the seven- variant of the dopamine D4 receptor gene in patients with obsessive-compulsive disorders with tics. Neurosci Lett 1997; 231: 1–4.
Nicolini H, Cruz C, Camarena B, Orozco B, Kennedy JL, King N et al. DRD2, DRD3, and 5HTDA receptor genes polymorphisms in obsessive-compulsive disorder. Mol Psychiatry 1996; 1: 461–465.
Nicolini H, Cruz C, Páez F, Camarena B . Los genes de los receptores a dopamina D2 y D4 distinguen la presencia clínica de tics en el trastorno obsesivo-compulsivo. Gac Med Mex 1998; 8: 163–169.
Urraca N, Camarena B, Gomez-Caudillo L, Esmer MC, Nicolini H . Micro opioid receptor gene as a candidate for the study of obsessive compulsive disorder with and without tics. Am J Med Genet 2004; 127B: 94–96.
Kelsoe JR . Arguments for the genetic basis of the bipolar spectrum. J Affect Disord 2003; 73: 183–197.
Reif A, Lesch KP . Toward a molecular architecture of personality. Behav Brain Res 2003; 139: 1–20.
Jonnal AH, Gardner CO, Prescott CA, Kendler KS . Obsessive and compulsive symptoms in a general population sample of female twins. Am J Med Genet 2000; 96: 791–796.
Eley TC, Bolton D, O'Connor TG, Perrin S, Smith P, Plomin R . A twin study of anxiety-related behaviours in pre-school children. J Child Psychol Psychiatry 2003; 44: 945–960.
Capstick N, Seldrup J . Obsessional states. A study in the relationship between abnormalities occurring at the time of birth and the subsequent development of obsessional symptoms. Acta Psychiatr Scand 1977; 56: 427–431.
Lensi P, Cassano GB, Correddu G, Ravagli S, Kunovac JL, Akiskal HS . Obsessive-compulsive disorder—familial–developmental history, symptomatology, comorbidity and course with special reference to gender-related differences. Br J Psychiat 1996; 169: 101–107.
Santangelo SL, Pauls DL, Goldstein J, Faraone SV, Tsuang MT, Leckman JF . Tourette's syndrome: what are the influences of gender and comorbid obsessive-compulsive disorder? J Am Acad Child Adolesc Psychiatry 1994; 33: 795–804.
Peterson BS, Leckman JF, Scahill L, Naftolin F, Keefe D, Charest NJ et al. Hypothesis: steroid hormones and sexual dimorphisms modulate symptom expression in Tourette's syndrome. Psychoneuroendocrinology 1992; 17: 553–563.
Altemus M, Greenberg BD, Keuler D, Jacobson KR, Murphy DL . Open trial of flutamide for treatment of obsessive-compulsive disorder. J Clin Psychiatry 1999; 60: 442–445.
Pollitt J . Natural history of obsessional states. BMJ 1957; 9: 133–140.
Ingram IM . Obsessional illness in mental hospital patients. J Mental Sci 1961; 107: 382–402.
Lo WH . A follow-up study of obsessional neurotics in Hong Kong Chinese. Br J Psychiatry 1967; 113: 823–832.
Neziroglu F, Anemone R, Yaryura-Tobias J . Onset of obsessive-compulsive disorder in pregnancy. Am J Psychiatry 1992; 149: 947–950.
Maina G, Albert U, Bogetto F, Vaschetto P, Ravizza L . Recent life events and obsessive-compulsive disorder (OCD): the role of pregnancy/delivery. Psychiatry Res 1999; 89: 49–58.
Abramowitz JS, Schwartz SA, Moore KM, Luenzmann KR . Obsessive-compulsive symptoms in pregnancy and the puerperium: a review of the literature. J Anxiety Disord 2003; 17: 461–478.
Abramowitz J, Moore K, Carmin C, Wiegartz PS, Purdon C . Acute onset of obsessive-compulsive disorder in males following childbirth. Psychossomatics 2001; 42: 429–431.
Leckman JF, Goodman WK, North WG, Chappell PB, Price LH, Pauls DL et al. Elevated levels of CSF oxytocin in obsessive compulsive disorder: comparison with Tourette's syndrome and healthy controls. Arch Gen Psychiatry 1994; 51: 782–792.
Leckman JF, Mayes LC, Feldman R, Evans D, King RA, Cohen DJ . Early parental preoccupations and behaviors and their possible relationship to the symptoms of obsessive-compulsive disorder. Acta Psychiat Scand 1999; 100(Suppl 396): 1–26.
McKeon J, Roa B, Mann A . Life events and personality traits in obsessive-compulsive neurosis. Br J Psychiatry 1984; 144: 185–189.
Khanna S, Rajendra PN, Channabasavanna SM . Live events and onset of obsessive-compulsive disorder. Int J Soc Psychiatry 1988; 34: 305–309.
Gershuny BS, Baer L, Radomsky AS, Wilson KA, Jenike MA . Connections among symptoms of obsessive-compulsive disorder and posttraumatic stress disorder: a case series. Behav Res Ther 2003; 41: 1029–1041.
Gershuny BS, Baer L, Radomsky AS, Wilson KA, Jenike MA . Comorbid posttraumatic stress disorder: impact on treatment outcome for obsessive-compulsive disorder. Am J Psychiatry 2002; 159: 852–854.
Swedo SE . Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). Mol Psychiatry 2002; 7(Suppl 2): S24–S25.
Asbahr FR, Negrao AB, Gentil V, Zanetta DM, da Paz JA, Marques-Dias MJ et al. Obsessive-compulsive and related symptoms in children and adolescents with rheumatic fever with and without chorea: a prospective 6-month study. Am J Psychiatry 1998; 155: 1122–1124.
Mercadante MT, Busatto GF, Lombroso PJ, Prado L, Rosario-Campos MC, do Valle R et al. The psychiatric symptoms of rheumatic fever. Am J Psychiatry 2000; 157: 2036–2038.
Hounie AG, Pauls DL, Mercadante MT, Rosario-Campos MC, Shavitt RG, De Mathis MA et al. Obsessive-compulsive spectrum disorders in rheumatic fever with and without Sydenham's chorea. J Clin Psychiatry 2004; 65: 994–999.
Mercadante MT, Hounie AG, Muniz JB, Miguel EC, Lombroso PJ . The basal ganglia and immune-based neuropsychiatric disorders. Psychiatric Annals 2001; 31: 534–540.
Guilherme L, Kalil J . Rheumatic fever: the T cell response leading to autoimmune aggression in the heart. Autoimmun Rev 2002; 1: 261–266.
Kirvan CA, Swedo SE, Heuser JS, Cunningham MW . Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med 2003; 9: 914–920.
Donadi EA, Smith AG, Louzada-Junior P, Voltarelli JC, Nepom GT . HLA class I and class II profiles of patients presenting with Sydenham's chorea. J Neurol 2000; 247: 122–128.
Stanevicha V, Eglite J, Sochnevs A, Gardovska D, Zavadska D, Shantere R . HLA class II associations with rheumatic heart disease among clinically homogeneous patients in children in Latvia. Arthritis Res Ther 2003; 5: R340–R346.
Cunningham MW . Pathogenesis of groups A streptococcal infections. Microbiol Rev 2000; 13: 470–511.
Murphy T, Goodman W . Genetics of childhood disorders: XXXIV. Autoimmune disorders, part 7: D8/17 reactivity as an immunological marker of susceptibility to neuropsychiatric disorders. J Am Acad Child Adolesc Psychiatry 2002; 41: 98–100.
Inoff-Germain G, Rodriguez RS, Torres-Alcantara S, Diaz-Jimenez MJ, Swedo SE, Rapoport JL . An immunological marker (D8/17) associated with rheumatic fever as a predictor of childhood psychiatric disorders in a community sample. J Child Psychol Psychiatry 2003; 44: 782–790.
Zai G, Bezchlibnyk YB, Richter MA, Arnold P, Burroughs E, Barr CL et al. Myelin oligodendrocyte glycoprotein (MOG) gene is associated with obsessive-compulsive disorder. Am J Med Genet 2004; 129: 64–68.
Lougee L, Perlmutter SJ, Nicolson R, Garvey MA, Swedo SE . Psychiatric disorders in first-degree relatives of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). J Am Acad Child Adolesc Psychiatry 2000; 39: 1120–1126.
Rauch SL . Preparing for psychiatry in the 21st century. In: Stern TA, Herman JB (eds) Psychiatry Update and Board Preparation. McGraw-Hill: New York, 2000, pp 579–583.
Rauch SL, Shin LM, Dougherty DD, Alpert NM, Fischman AJ, Jenike MA . Predictors of fluvoxamine response in contamination-related obsessive-compulsive disorder: a PET symptom provocation study. Neuropsychopharmacology 2002; 27: 782–791.
Saxena S, Rauch SL . Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatr Clin N Am 2000; 23: 563–586.
Kosslyn SM, Plomin R . Toward a neurocognitive genetics: goals and issues. In: Dougherty DD, Rauch SL (eds) Psychiatric Neuroimagaign Research: Contemporary Strategies. American Psychiatric Publishing Inc.: Washington, DC, 2001, pp 383–402.
Saxena S, Brody AL, Ho ML, Alborzian S, Ho MK, Maidment KM et al. Cerebral metabolism in major depression and obsessive-compulsive disorder occurring separately and concurrently. Biol Psychiatry 2001; 50: 159–170.
Busatto GF, Buchpiguel CA, Zamignani DR, Garrido GEJ, Glabus MF, Rosario-Campos MC et al. Regional cerebral blood flow differences in obsessive-compulsive disorder subtyped according to the age of illness onset. J Am Acad Child Adolesc Psychiatry 2001; 40: 347–354.
Phillips ML, Marks IM, Senior C, Lythgoe D, O'Dwyer A-M, Meehan O et al. A differential neural response in obsessive-compulsive disorder patients with washing compared with checking symptoms to disgust. Psychol Med 2000; 30: 1037–1050.
Saxena S, Brody AL, Maidment KM, Smith EC, Zohrabi N, Katz E et al. Cerebral glucose metabolism in obsessive-compulsive hoarding. Am J Psychiatry 2004; 161: 1038–1048.
Mataix-Cols D, Woonderson S, Lawrence N, Brammer MJ, Speckens A, Phillips ML . Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder. Arch Gen Psychiatry 2004; 61: 564–576.
Pujol J, Soriano-Mas C, Alonso P, Cardoner N, Menchon JM, Deus J et al. Mapping structural brain alterations in obsessive-compulsive disorder. Arch Gen Psychiatry 2004; 61: 720–730.
Hariri AR, Weinberger DR . Imaging genomics. Br Med Bull 2003; 65: 259–270.
Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D et al. Serotonin transporter genetic variation and the response of the human amygdala. Science 2002; 297: 400–403.
McDougle CJ, Goodman WK, Leckman JF, Lee NC, Heninger GR, Price LH . Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder: a double-blind placebo-controlled study in patients with and without tics. Arch Gen Psychiatry 1994; 51: 302–308.
McDougle CJ, Goodman WK, Leckman JF, Barr LC, Heninger GR, Price LH . The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder. J Clin Psychopharmacol 1993; 13: 354–358.
Erzegovesi S, Cavallini MC, Cavedini P, Diaferia G, Locatelli M, Bellodi L . Clinical predictors of drug response in obsessive-compulsive disorder. J Clin Psychopharmacol 2001; 21: 488–492.
Alarcon LD, Llibb JW, Spitler D . A predictive study of obsessive-compulsive disorder response to clomipramine. J Clin Psychopharmacol 1993; 13: 210–213.
Neziroglu FA, Stevens PK, Yaryura-Tobias JA . Overvalued ideas and their impact on treatment outcome. Rev Bras Psiquiatr 1999; 21: 209–216.
Mundo E, Erzegovesi S, Bellodi L . Follow-up of obsessive-compulsive patients treated with proserotonergi agents. J Clin Psychopharmacol 1995; 15: 288–289.
Baer L, Jenike MA, Black DW, Treece C, Rosenfeld R, Greist J . Effects of Axis II diagnoses on treatment outcome with clomipramine in 55 patients with obsessive-compulsive disorder. Arch Gen Psychiatry 1992; 49: 862–866.
McDougle CJ, Goodman WK, Price LH, Delgado PL, Krystal JH, Charney DS et al. Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder. Am J Psychiatry 1990; 147: 652–654.
Minichiello WE, Baer L, Jenike MA . Schizotypal personality disorder: a poor prognostic indicator for behavior therapy in the treatment of obsessive-compulsive disorder. J Anxiety Disord 1987; 1: 273–276.
Hollander E, Bienstock CA, Koran LM, Pallanti S, Marazziti D, Rasmussen SA et al. Refractory obsessive-compulsive disorder state-of-art treatment. J Clin Psychiatry 2002; 63(Suppl 6): 20–29, (review).
Neziroglu F, Pinto A, Yaryura-Tobias JA, McKay D . Overvalued ideation as a predictor of fluvoxamine response in patients with obsessive-compulsive disorder. Psychiatry Res 2004; 125: 53–60.
McDougle CJ, Epperson CN, Price LH, Gelernter J . Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive-compulsive disorder. Mol Psychiatry 1998; 3: 270–273.
Di Bella D, Erzegovesi S, Cavallini MC, Bellodi L . Obsessive-compulsive disorder, 5-HTTLPR polymorphism and treatment response. Pharmacogenomics J 2002; 2: 176–181.
Wong ML, Licinio J . From monoamines to genomic targets: a paradigm shift for drug discovery in depression. Nat Rev Drug Discov 2004; 3: 136–151.
Rosario-Campos MC, Miguel EC, Quatrano S, Chacon P, Ferrao Y, Findley D et al. The Dimensional Yale–Brown Obsessive Compulsive Scales (DY-BOCS): a new instrument for assessing obsessive-compulsive symptom dimensions, submitted.
US